AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 101 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,159,888 | -42.6% | 1,435,553 | -0.2% | 0.00% | -50.0% |
| Q2 2023 | $15,953,523 | -20.2% | 1,438,550 | +10.5% | 0.00% | -33.3% |
| Q1 2023 | $19,986,211 | +80149.8% | 1,302,033 | +16.0% | 0.00% | 0.0% |
| Q4 2022 | $24,905 | -99.8% | 1,122,378 | +19.4% | 0.00% | +50.0% |
| Q3 2022 | $15,344,000 | +24.4% | 939,624 | +10.7% | 0.00% | 0.0% |
| Q2 2022 | $12,331,000 | -9.4% | 848,701 | +15.1% | 0.00% | 0.0% |
| Q1 2022 | $13,614,000 | -19.8% | 737,096 | +3.2% | 0.00% | 0.0% |
| Q4 2021 | $16,977,000 | -6.8% | 714,241 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $18,208,000 | +78.6% | 739,266 | +79.1% | 0.00% | +100.0% |
| Q2 2021 | $10,197,000 | +15.3% | 412,677 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $8,847,000 | +30.5% | 405,674 | +52.7% | 0.00% | 0.0% |
| Q4 2020 | $6,777,000 | -11.0% | 265,588 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $7,618,000 | +1493.7% | 270,637 | +1498.5% | 0.00% | – |
| Q2 2020 | $478,000 | – | 16,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |